Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Cryo Cell International (CCEL) Long-Term Debt Issuances (2016)

Cryo Cell International (CCEL) reported Long-Term Debt Issuances of $10.1 million for Q3 2016.

Cryo Cell International (CCEL) has 1 years of Long-Term Debt Issuances data on file, last reported at $10.1 million in Q3 2016.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $10.1 million in Q3 2016, while the trailing twelve-month figure through Nov 2021 was $10.1 million (changed N/A YoY) and the FY2022 annual result came in at $9.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances steadied at $10.1 million in Q3 2016 per CCEL's latest filing.
  • Across five years, Long-Term Debt Issuances topped out at $10.1 million in Q3 2016 and bottomed at $10.1 million in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 14.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 1.26 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 250.00 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 582.91 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 135.48 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Cryo Cell International 27.15 Mn 24.25 Mn 6.03 Mn -

Historic Data

Download Data 🔒
DateValue
Aug 31, 2016 10.13 Mn
Aug 31, 2016 10.13 Mn